Sulfated carbohydrates on the cell surface and in the extracellular space perform various biological functions e.g., as important mediators of extracellular traffic and cell-cell communication.
INTRODUCTION

6SGN.
5 7) However, these chemical synthetic procedures generally require multi-step pathways and are unsatisfactory for obtaining the target compounds in reasonable yield. Recently, the focus of this research has switched to enzymatic methods because of their relatively high efficiency and the ecofriendly aspects of these processes.
8 10) Gambaryan et al. reported the synthesis of a panel of polyacrylamide (PA)-based sialoglycopolymers with similar terminal fragments that varied only in the next saccharide residue.
11) Substitution of the 6-hydroxyl group of the N-acetylglucosamine (GlcNAc) residue by the 6-sulfo group in the sialoglycopolymers showed a dramatic increase in receptor binding by H5N1 chicken influenza viruses. Unfortunately, however, these glycopolymers with a PA backbone are known to toxic due to contaminated monomeric acrylamide.
11 15) In our previous study, γ-polyglutamic acid (γ-PGA), a natural substance produced from Bacillus subtilis, was found to be a good backbone for glycopolymers carrying multivalent glycans against viruses and carbohydrate-binding proteins such as lectins. 16, 17) In particular, there are physiological merits in utilizing γ-PGA as a backbone for glycopolymers in terms of reduced cytotoxicity and immunogenicity. We were therefore interested in developing an efficient synthetic route to 6-O-sulfated sialoglycopolypeptides that can be incorporated in γ-PGA as potential inhibitors of influenza virus hemagglutinin. Here, we describe a novel and facile synthesis of artificial glycopolypeptides carrying the Neu5Acα2,3-and Neu5Acα2,6Galβ1,4(6-sulfo)GlcNAc residues.
RESULTS AND DISCUSSION
Synthesis of 5-aminopentyl β-6-O-sulfo-N-acetylglucosami nide (5-AP-β-6SLN, 3).
We recently reported the 6-O-sulfo-N-acetylglucosaminyl transfer reaction by β-N-acetylhexosaminidase (β-NAHase) Fig. 1. (1) Enzymatic synthesis of 5-TFAP-β-6SLN 2, (2) coupling of 3 with γ-PGA and (3) sialylation to highly water-soluble sulfated asialoglycopolypeptides 4 for the synthesis of sulfated sialoglycopolypeptides 5 and 6.
from Aspergillus oryzae. 18, 19) In these paper, a series of 6-O-sulfo-N-acetylglucosaminyl disaccharides with different aglycons at the anomeric positions could be prepared using β-D-6-O-sulfo-GlcNAc-O-pNP (6SGN-β-pNP) as the glycosyl donor and glucose and GlcNAc derivatives having different aglycons as the glycosyl acceptors, showing the utility of the transglycosylation of this enzyme with high regioselectivity. In this article, we apply our enzymatic method for the synthesis of 6-O-sulfated N-acetyllactosaminide 3 with a hydrophobic spacer, a 5-aminopentyl group, at the reducing end as the key material.
Besides our previous enzymatic methods mentioned above, we recently demonstrated the importance of the spacer moiety between the glycans required for virus recognition and the polymer main chains when hemagglutinin inhibitors of influenza viruses were studied. 20, 21) Here, the 5-aminopentyl group was selected as an appropriate hydrophobic spacer for the influenza hemagglutinin assay. Figure 1 showed the synthesis of sulfated sialoglycopolypeptides (5 and 6) as the targets. Initially, the 6SGN-β-pNP donor and the 5-trifluoroacetamido-1-pentanol acceptor were incubated with partially purified β-NAHase from A. oryzae at 40 C. The molar ratio of the donor to the acceptor was 1:10, and the total substrate concentration in the reaction mixture was 27% (w/v). The enzymatic conversion was monitored by the high performance liquid chromatography (HPLC) analysis of 5 µL aliquots taken from the reaction mixture. The chromatogram showed that only one transfer product 5-TFAP-β-6SGN (1, Rt 26.307 min) was formed during the incubation (see the Experimental section). The reaction mixture was easily purified by ODS column chromatography to produce compound 1 in high yield (72% based on the amount of donor added; see Fig. 1 ). The structure of 1 was confirmed by NMR analysis. In the 1 H NMR spectrum of 1, compound 1 has a β-linkage (J1,2 8.5 Hz). In the 13 C NMR spectrum of compound 1, the C-1 signal had clearly shifted downfield (δ 104.0 ppm). HRESI-MS spectrum also supported the structure of the sulfo disaccharide product (527.08930 [M + Na] + ). These results indicate that β-NAHase from A. oryzae can catalyze β-specific transglycosylation between 6SGN-β-pNP and alkanol acceptors with a primary hydroxyl group such as 5-trifluoroacetamido-1-pentanol, giving the desired compound 1. Using UDP-Gal as the donor and β1,4-galactosyltransferase (β1,4GalT), selective galactosylation of 1 was carried out to give galactosyl disaccharide 2. Finally, the resulting sulfated disaccharide glycoside 2 was quantitatively converted to 5-AP-β-6SLN (3) by hydrolysis in 1 M NaOH aqueous solution. The target product 3 was synthesized in a high total yield of 62%. Chemo-enzymatic synthesis of sulfated sialoglycopolypeptides.
The amino function of compound 3 was reacted with the carboxyl groups of γ-PGA in the presence of the condensation reagents benzotriazol-1-yloxytris-(dimethylamino) phosphonium hexafluorophosphate (BOP) and 1-hydroxybenzotriazole hydrate (HOBt), as described earlier ( Fig. 1 and Table 1) . 16) In this study, γ-PGA of 990 kDa was used as the polypeptide backbone. After being reacted with the polypeptide and 3, the reaction mixture was applied to a column of Sephadex G-25M PD-10 to separate the target poly[Galβ1,4(6-sulfo)GlcNAcβ-O(CH2)5NH-/γ-PGA] 4 from the low molecular weight reactants. The degree of substitution (DS) in the mole fraction of the substituted residues in 4 was analyzed by 1 H NMR analysis based on the relative intensities of signals due to peptide methylene protons and those due to spacer-linked methylene protons in the aglycon (Fig. 2) . The DS in 4 was determined to be 44% as shown in Table 1 . Using α2,3-and α2,6-sialyltransferases (α2,3SiaT and α2,6SiaT), sialylation of the asialoglycosyl residues in glycopolypeptide 4 successfully proceeded to give α2,3-sialylated 5 and α2,6-sialylated 6, respectively ( Fig. 1 and Table 2 ). In this case, the sialylation was easily performed even in the presence of 6-O-sulfo groups in the asialoglycopolypeptide residues. The structures of the 6-O-sulfated sialoglycopolypeptides 5 and 6 were elucidated by 1 H and 13 C NMR analyses. The DS of sialyl sugars derived from 5 and 6 were determined by 1 H NMR, and chemical analysis together with HPLC analysis after derivatization with 1,2-diamino-4,5-methylenedioxybenzene (DMB) 22) was also supported to be 5 and 6.
Hemagglutination inhibition assay of the synthetic glycopolypeptides using avian and human influenza viruses.
Various substances carrying sialooligosaccharides are known to inhibit hemagglutination by binding to viral hemagglutinin. 16, 20, 23, 24) In this study, the hemagglutination inhibition activity of the synthetic 6-O-sulfated sialoglycopolypeptides was examined and compared to that of the corresponding non-sulfated sialoglycopolypeptides (Table  3 ). The avian virus A/Duck/HongKong/313/4/78 (H5N3) reacted specifically with the sialoglycopolypeptides carrying an α2,3 sialylated glycan. Compound 5, which is modified by 6-O-sulfation, was shown to be the most effective inhibitor (IC50 19 nM) among the glycopolypeptides tested. The relative binding affinity of 5 was 1.2 10 3 -fold higher than that of fetuin itself, which binds with avian and human types of influenza virus due to the presence of both sialic acid linkages, α2,3 and α2,6.
25,26) The polymer showed a slightly higher inhibitory activity than 7 (IC50 38 nM), which was the reference compound. The results of these inhibition experiments are comparable to those of Gambaryan et al., 11) which showed that the avian viruses were inhibited by synthetic PA-based sialoglycopolymers carrying sulfated trisaccharide.
27,28) By contrast, the human virus A/Aichi/2/68 (H3N2) reacted specifically with the sialoglycopolypeptides carrying an α2,6 sialylated glycan. The relative binding affinity of 6, which carries a 6-O-sulfation modification, was 4.9 10 2 -fold higher than that of fetuin. The corresponding effect of 6-O-sulfation against sialoglycopolypeptides was not observed for human virus A/Aichi/2/68 (H3N2). Moreover, 6-O-sulfated α2,3-sialoglycopolypeptide 5 weakly inhibited hemagglutination mediated by human virus A/Aichi/2/68 (H3N2) to the same extent as non-sulfated α2,3-sialoglycopolypeptide 7. Furthermore, influenza virus-mediated hemagglutination was not affected by the 6-O-sulfated asialoglycopolypeptide 4.
In conclusion, we have developed an effective chemoenzymatically based method to synthesize artificial 6-O-sulfated sialoglycopolypeptides (5 and 6) with a γ-PGA backbone. In particular, we found that β-NAHase purified from A. oryzae catalyzed the 6SGN transfer reaction to an alkanol acceptor with a primary hydroxyl group in high yield. Finally, the polymeric Neu5Acα2,3Galβ1,4(6-sulfo) GlcNAc is known to be a potent inhibitor of H5N1 chicken influenza virus.
11,29) Thus, compound 5 is a potentially valuable antiviral agent.
EXPERIMENTAL
General methods. γ-PGA-Na (MW 990,000) from B. subtilis was a kind gift from Meiji Food Material Co. (Odawara, Japan). UDP-Gal and CMP-Neu5Ac were gifts from Yamasa Corporation (Chiba, Japan). Bovine milk β1,4GalT, α2,3SiaT (rat recombinant, Spodoptera frugiperda) and α2,6SiaT (rat recombinant, S. frugiperda) were purchased from Calbiochem-Novabiochem Corp. (San Diego, USA). Sialoglycopolypeptides {7 poly[Neu5Acα2, 3Galβ1,4GlcNAcβ-O(CH2)5NH-/γ-PGA] and 8 poly[Neu5 Acα2,6Galβ1,4GlcNAcβ-O(CH2)5NH-/γ-PGA]}, 6SGN-β-pNP and β-NAHase (E.C. 3.2.1.52) from A. oryzae were prepared by previously reported methods.
19,20) The human and avian influenza virus strains used in this study were propagated and purified as described previously.
30,31) Viral hemagglutination units (HAUs) of purified viruses were determined using an established protocol. 32) All other reagents were of the highest quality commercially available and were used without further purification. Enzyme assay. β-NAHase and β1,4GalT activities were assayed by previously described methods.
19,20)
HPLC determination of sialic acids in the artificial glycopolypeptides. Sialic acids of the artificial glycopolypeptides were determined by previously described DMBlabeled HPLC method.
20)
Analytical methods. The HPLC system consisted of a TSKgel ODS-80TsQA column (4.6 250 mm; Tosoh Corp., Tokyo, Japan), a JASCO Corp. (Tokyo, Japan) Intelligent System Liquid Chromatograph, with detection set at 210 nm. Bound material was eluted in 0.1% TFA/10% methanol at a flow rate of 1.0 mL/min and a temperature of 40 C. The electrospray ionization (ESI) mass spectra were measured on a JMS-T100LC mass spectrometer (JEOL Ltd., Tokyo, Japan). 500-MHz 1 H NMR spectra and 125-MHz 13 C NMR spectra were recorded using a JEOL lambda-500 spectrometer. Chemical shifts were expressed in ppm relative to the methyl resonance of the external standard sodium 3-(trimethylsilyl) propionate.
Enzymatic synthesis of 5-TFAP-β-6SGN (1).
A mixture containing 0.4 mmol of 6SGN-β-pNP, 4.0 mmol of 5-trifluoroacetamido-1-pentanol, and partially purified β-NAHase (25 U of GlcNAc-β-pNP hydrolytic activity) in 4.0 mL of 10 mM sodium acetate buffer (pH 5.5) was incubated for 144 h at 40 C. The reaction was quenched by heating the mixture to 100 C for 5 min and the solution was clarified by centrifugation at 8,000
G for 15 min. The resulting supernatant was then loaded onto an ODS column (3.5 60 cm) equilibrated with distilled water. The column was developed with distilled water at a flow rate of 2.0 mL/min, and a fraction size of 25 mL was collected. An aliquot from pooled fractions 26 44 was concentrated and lyophilized. Compound 1 was obtained in a yield of 72% (162. Compound 1 (130 mg, 0.26 mmol) and UDP-Gal (315 mg, 0.52 mmol) were dissolved in 50 mM MOPS buffer pH 7.4 (24.8 mL) containing 8 mM MnCl2, 1 mg/mL BSA and 0.01% (w/v) NaN3, followed by addition of 2 U (1.0 mL) of partially purified β1,4GalT from bovine milk. The mixture was incubated for 120 h at 37 C and then the reaction was terminated by heating at 100 C for 5 min. The precipitate was removed by centrifugation (8,000 G, 20 min) and the supernatant was loaded onto an ODS column (3.5 60 cm) equilibrated with distilled water. The column was developed with distilled water at a flow rate of 3.0 mL/min, and a fraction size of 22 mL. The eluate was monitored by measuring the absorbance at 210 nm using a spectrophotometer. (1H, H-αb), 3.83-3.71 (7H, H-2, H-3, H-4, H-5, H-5 , H-6 b, H-6 a), 3.68 (dd, 1H, J2 ,3 10, J3 ,4 3.5 Hz, H-3 ), 3.65 (1H,  H-αa), 3.54 (dd, 1H, J1 ,2 8.0, J2 ,3 10 Hz, H-2 ), 3.00 (2H, H-ε), 2.04 (s, 3H, CH3CONH-), 1.71-1.59 (4H, H-β, H-δ), 1.42 (2H, H-γ);
13 C NMR (D2O, 125 MHz): δ 177.3 (CH3CONH-), 105.4 (C-1 ), 104.0 (C-1), 80.5 (C-4), 78.2 (C-5 ), 75.4 (C-5), 75.3 (C-3 ), 75.2 (C-3), 73.8 (C-2 ), 73.1 (C-α), 71.4 (C-4 ), 69.3 (C-6), 63.9 (C-6 ), 57.9 (C-2), 42.2 (C-ε), 30.9 (C-β), 29.1 (C-δ), 25.0 (CH3CONH-), 24.9 (C-γ). Synthesis of poly[Galβ1,4(6-sulfo)GlcNAcβ-O(CH2)5NH-/ γ-PGA] (4). The amino group of 3 was coupled to the carboxyl group of γ-PGA by a condensation reaction using BOP and HOBt. The DS of the substituted residues in the glycopolypeptide was adjusted to 44%. The DS in terms of the mole fraction of substituted residues in the glycopolypeptide was calculated as a percentage from the relative intensities of the 1 H NMR signal areas of peptide γ-methylene protons and aglycon ε-methylene protons. Compound 4 was prepared from 3 according to our previously reported method.
16 ) Compound 5 was synthesized enzymatically from 4 as follows. A mixture containing 6.2 mg of 4, 16.0 mM CMP-Neu5Ac, 40 mU/mL of α2,3SiaT, 2.5 mM MnCl2, 1.0 mg/mL BSA and 10 U/mL of calf intestine alkaline phosphatase (Boehringer-Mannheim GMBH, Mannheim, Germany) in 50 mM MOPS buffer (pH 7.4) was incubated at 37 C for 48 h in a total volume of 873 µL. The reaction was stopped by heating the mixture to 100 C for 5 min. After centrifugation, the clarified supernatant from the reaction mixture was loaded onto a Sephadex G-25M PD-10 column equilibrated with 100 mM PBS (pH 7.4). The high-molecular-weight fraction was collected and dialyzed against distilled water for three days and then lyophilized to afford poly[Neu5Acα 2,3Galβ1,4(6-sulfo)GlcNAcβ-O(CH2)5NH-/γ-PGA] 5 (7.4 mg). (dd, 1H, J3"ax,3"eq 12.0, J3"eq,4" 4.4 Hz, H-3"eq), 2.40 (2H, γ-methylene, γ-PGA), 2.25 1.85 (2H, β-methylene, γ-PGA), 2.04 (s, 6H, CH3CONH-", CH3CONH-), 1.81 (t, 1H, J3"ax,3"eq 12.0, J3"ax,4" 12. 0 Hz, H-3"ax), 1.56 (2H, H-ω), 1.51 (2H, H-β), 1.31 (2H, H-γ);
13
C NMR (D2O, 125 MHz): δ 177.7 (CH3CONH-, CH3CONH-"), 175.3 (HOOC-"), 105.0 (C-1′), 103.9 (C-1), 102.6 (C-2"), 80.1 (C-4), 78.2 (C-5′), 77.9 (C-3′), 75.7 (C-6"), 75.4 (C-5), 75.1 (C-3), 74.3 (C-8"), 73.2 (C-a) , 72.3 (C-2′), 71.3 (C-4"), 71.0 (C-7"), 70.4 (C-4′), 69.1 (C-6), 65.4 (C-9"), 63.9 (C-6′), 57.9 (C-2), 56.4 (α-methine, γ-PGA), 54.6 (C-5"), 42.4 (C-3"), 42.2 (C-e), 34.1 (γ-methylene, γ-PGA), 31.0 (C-β), 30.8 (C-ω), 29.9 (β-methylene, γ-PGA), 25.2 (C-γ), 25.1 (CH3CONH-), 24.9 (CH3CONH-"). Compound 6 was similarly synthesized from compound 4 using α2,6SiaT (40 mU/mL) to afford poly[Neu5Acα2,6Galβ1,4(6-sulfo)GlcNAcβ-O(CH2)5NH-/ γ-PGA] 6 (6.7 mg). .0 (C-7"), 69.5 (C-6), 66.1 (C-6′), 65.5 (C-9"), 57.7 (C-2), 56.5 (α-methine, γ-PGA), 54.8 (C-5"), 42.9 (C-3"), 42.2 (C-e), 34.4 (γ-methylene, γ-PGA), 31.0 (C-β), 30.8 (C-ω), 29.9 (β-methylene, γ-PGA), 25.2 (C-γ, CH3CONH-), 24.9 (CH3CONH-). Hemagglutination inhibition assay. The hemagglutination inhibition (HI) assay was carried out using 96-well microtiter plates as described previously.
33) Phosphatebuffered saline (PBS, pH 7.4) was used as a dilution buffer. Virus suspension (2 2 HAUs in 0.025 mL of PBS) was added to each well containing the synthetic glycopolypeptides (200 to 0.024 nM) in a two-fold serial dilution in dilution buffer. After incubation at 4 C for 1 h, 0.05 mL of 0.6% (v/v) guinea-pig erythrocyte suspension was added to the plates. The mixture was then stored for 2 h at 4 C. The maximum dilution of the samples showing complete inhibition of hemagglutination was defined as the HI titer. 
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